CD49d was first proposed by Bowman and coworkers as a marker of MDMs in experimental murine gliomas [59], and it was confirmed as a good surface marker of monocytes and MDMs in human brain tumors [69,101]. The gene discussed is ITGA4; the disease is central nervous system cancer.